儿童和青少年的阴道和子宫瘤:一个基于SEER人口的SEER研究
Yi Shi1, Wenyuan Liu1, Meiping Zhu1
1Department of Pediatrics, First Affiliated Hospital of Huzhou University, The First People's Hospital of Huzhou, Huzhou, 313000, China.
Pediatric surgery international
|June 10, 2025
概括
儿科的阴道和子宫瘤是罕见的. 年龄较小,局部疾病和特定亚型,如黄囊瘤 (YSTs),与儿童和青少年的更好的生存结果相关.
科学领域:
- 儿科瘤学 儿科瘤学
- 妇科瘤学 妇科瘤学
- 流行病学 流行病学
背景情况:
- 在儿科和青少年群体中,阴道和子宫瘤不常见,并没有很好的特征.
- 了解它们的发生率,治疗和结果对于改善患者护理至关重要.
研究的目的:
- 综合分析0-18岁患者的阴道和宫瘤的发病率,治疗方法和生存结果.
- 确定影响这种罕见儿科癌症群体生存的预后因素.
主要方法:
- 利用监测,流行病学和最终结果 (SEER) 数据库 (2000-2019) 来获取患者数据.
- 使用卡普兰-梅尔和多变量考克斯比例危险模型分析了人口统计,瘤特征,治疗和生存率.
- 开发了一种基于考克斯回归的结果进行结果预测的诺姆图.
主要成果:
- 分析了164例儿科和青少年病例;中位数年龄为14岁.
- 胚胎性拉布多米索尔科马是最常见的亚型 (40.9%).
- 五年整体生存率为88.9%. 年龄较小 (0-14岁),局部疾病和特定亚型 (例如,黄囊瘤) 与更好的预后有关,而远程转移表明结果较差.
结论:
- 儿科的阴道和子宫瘤表现出独特的人口和临床特征.
- 有利的预后指标包括年轻的年龄,局部疾病和某些组织学类型,如YSTs.
- 强调早期诊断的重要性,并为最佳结果量身定制多式联络治疗策略.
相关概念视频
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Disorders of the Female Reproductive System
3.9K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.9K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


